FDA Approved: EMPAVELI — Original Application (Apellis Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved EMPAVELI (pegcetacoplan) from Apellis Pharmaceuticals as a treatment for adults with paroxysmal nocturnal hemoglobinuria who require regular tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• EMPAVELI (pegcetacoplan)

Snippet

ORIG AP for EMPAVELI (PEGCETACOPLAN)